C2‐α‐Dicarbonyl‐Mediated Intravasation‐Cognate Matrix Microenvironmental Glycation Privileges Cancer Cell Survival Over Endothelia
Abstract
ABSTRACT Aging and diabetes, risk factors for cancer, are characterized by high tissue levels of several dicarbonyl species; understanding their relative toxicity can help design targeted strategies. We hypothesize that contextual effects of distinct dicarbonyls on extracellular matrices (ECM) differentially tweak the homeostasis of transformed and untransformed cell niches within intravasative tumor microenvironments consisting of ECM, endothelia, and cancer cells. We show how glycation by three best‐studied dicarbonyls: the C2‐α‐dicarbonyls methylglyoxal (MGO) and glyoxal (GO), and the C6‐α‐dicarbonyl 3‐deoxyglucosone (3‐DG), of two ECMs: Collagen I and laminin‐rich basement membrane (lrBM), differentially alters their morphodynamic interactions with untransformed human endothelia TeloHAEC and aggressive triple negative breast cancer MDA‐MB‐231 cells. We identify disruption in endothelial morphogenesis and adhesion, an increase in cancer cell de‐adhesion, and motility dynamics upon exposure of lrBM to C2‐α‐dicarbonyls, but not 3‐DG. This is due to dissolution of the migration‐inhibitive ECM by glycation. Similar effects are observed on Collagen I substrata due to matrix hyperpolymerization through picrosirius staining. Decreased adhesion not only ensures relative viability of cancer cells over endothelia; the latter exposed to C2‐α‐dicarbonyl‐glycated ECM exhibit even greater cell death. In summary, C2‐α‐dicarbonyls specifically can privilege the survival of cancer cells over endothelia through altering ECM adhesion.